Health

The Tamiflu Timeline

A timeline of key links and articles, in response to the drugs company Roche not publishing all clincal trial data on Tamiflu.

  1. 10th April 2013
  2. Prescribed #Tamiflu this flu season? Is there GOOD evidence for it? #Cochrane has something to say. #journalclub cochrane.org/features/neura…
  3. 5th April 2013
  4. 4th April 2013

    "The Cochrane group has cautiously welcomed the move, pointing out that Roche has previously promised access to data. MacLean’s email follows GlaxoSmithKline’s decision to release 30 clinical study reports on its influenza drug zanamivir (Relenza) to the same Cochrane group. The group is concerned, however, that data redaction and other problems may make analysis and interpretation impossible." Deborah Cohen, BMJ 
  5. 3 yrs after being asked Roche offers researchers results for all Tamiflu trials. bit.ly/ZBOAi2 Will they now sign up to #AllTrials?
  6. "It shouldn't have taken the researchers years of persistence and publicity to get these Tamiflu results," Sile Lane, director of campaigns at Sense about Science.
  7. 15th February 2013

    "The review reported a large effect on mortality. Yet, get this, the mortality result was based on only three studies. Three studies and you are on the essential medicines list, that can’t be right?"
    Carl Heneghan, Director of the Centre for Evidence-Based Medicine
  8. @juliaoftoronto:Canadian agency responds to pandemic planning bit.ly/12EDWJJ thoughts on the observational data tinyurl.com/conztsl
  9. Observational data for Tamiflu effects just doesn’t add up - tinyurl.com/conztsl (via @cebmblog)
  10. 29th January 2013
  11. 28th January 2013
  12. 17th January 2013
  13. "Last month, during peak flu hysteria, the Public Health Agency of Canada made an announcement: that it would release a bunch of the influenza drug Tamiflu from the emergency national stockpile to ensure all Canadians who needed the medication had access. The release was suspect for one key reason: it did not reflect any of the doubts and questions that have been raised by the international research community about Tamiflu, namely, recent high-quality studies that show the medicine may not be as effective as the drug-maker claims." Julia Belluz, http://www2.macleans.ca/science-ish/
  14. 15th January 2013
  15. Forbes.com (US) summarizes key points of 2012 #Cochrane Review of unpublished data on Tamiflu & Relenza: ow.ly/gJe6Y

Did you find this story interesting? or comment as 1 already did!

Liked!

UK Cochrane Centre

Storify is looked after by Holly & Sarah from UKCC. Holly is a Programme Support Officer looking after the marketing & communications side of things. Sarah is an Information Specialist, as well as being the UKCC head Tweeter & Blogger.

Total views
1,047

Storify

@Storify